MIRA INFORM REPORT

 

 

Report Date :

03.08.2013

 

IDENTIFICATION DETAILS

 

Name :

SAMRAT PHARMACHEM LIMITED (w.e.f. 24.07.1992)

 

 

Formerly Known As :

SAMRAT PHARMACHEM PRIVATE LIMITED

 

 

Registered Office :

Plot No.A2/3445, G.I.D.C., Phase–4, Ankleshwar – 393 002, Gujarat

 

 

Country :

India

 

 

Financials (as on) :

31.03.2012

 

 

Date of Incorporation :

16.06.1992

 

 

Com. Reg. No.:

04-017820

 

 

Capital Investment / Paid-up Capital :

Rs.30.897 Millions

 

 

CIN No.:

[Company Identification No.]

L24230GJ1992PLC017820

 

 

IEC No.:

0392065622

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

MUMS42633D

BRDS06273B

 

 

PAN No.:

[Permanent Account No.]

AAECS0806M

 

 

Legal Form :

Public Limited Liability Company. The Company’s Shares are Listed on the Stock Exchanges.

 

 

Line of Business :

Manufacturer, Exporter and Importer of Pharmaceutical Chemicals.

 

 

No. of Employees :

30 (Approximately)

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba (49)

 

RATING

STATUS

 

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Maximum Credit Limit :

USD 500000

 

 

Status :

Satisfactory

 

 

Payment Behaviour :

Usually Correct

 

 

Litigation :

Clear

 

 

Comments :

Subject is an established company having a satisfactory track record. The company has achieved better growth in its turnover during 2012.

 

Trade relations are reported as fair. Business is active. Payments are reported to be usually correct and as per commitments.

 

The company can be considered normal for business dealings at usual trade terms and conditions. 

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – March 31st, 2013

 

Country Name

Previous Rating

(31.12.2012)

Current Rating

(31.03.2013)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

INDIAN ECONOMIC OVERVIEW

 

We are living in a world where volatility and uncertainty have become the New Normal. We saw a change of government in countries like Tunisia, Egypt, Libya and Vietnam. Once powerful countries in Europe are now fighting for bankruptcy. We have taken growth in the developing part of the world for granted but economic growth in China and India has begun to slow. Companies that were synonymous with their product categories just a few years ago are now no longer in existence. Kodak, the inventor of the digital camera had to wind up its operations, HMV, the British entertainment retailing company and Borders, once the second largest bookstore have shut down due to their inability to evolve their business models with the changing time. Readers’ Digest, Thomson Register are no more !

 

There is another megatrend happening. The World order is changing as economic power shifts from West to East. According to McKinsey study, it took Britain more than 100 years to double its economic output per person during its industrial revolution and the US later took more than 50 years to do the same. More than a century later, China and India have doubled their GDP per capital in 12 and 18 years respectively. By 2020, emerging Asia will become the world’s largest consuming block, overtaking North America.

 

The years after the outbreak of the global financial crisis, the world economy continues to remain fragile. The Indian economy demonstrated remarkable resilience in the initial years of the contagion but finally lost ground last year. GDP growth slowed down. Currency has been weakening. There is a marked deceleration in agriculture, industry and services. Dampening sentiment led to a cut-back in investment as well as private consumption expenditure.  Inflation remained at high levels fuelled by the pressure from the food and fuel sectors. The large fiscal and current account deficit s continued to cause grave concern. It is imperative that India regains its growth trajectory of 8-9 % sooner than later. This is crucially important given the need to create gainful livelihood opportunities for the millions living in poverty as also the large contingent of young people joining the job market every year.

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2012.

 

INFORMATION PARTED BY

 

Name :

Mr. Rajesh Lalit Mehta

Designation :

Whole Time Director

Contact No.:

91-9321002222

Date :

11.06.2013

 

 

LOCATIONS

 

Registered Office/ Statutory Office/ Factory 1 :

Plot No.A2/3445, G.I.D.C., Phase–4, Ankleshwar – 393 002, Gujarat, India

Tel. No.:

91-2646-220774

Mobile No.:

91-9321002222 (Mr. Rajesh Mehta)

Fax No.:

91-2646-251291

E-Mail :

samrat@bom4.vsnl.net.in

Website :

http://www.samratpharmachem.com

Area :

3645 sq. mtr

Location :

Leased

 

 

Corporate Office 1 :

A/7, Sai Prasad, 2nd Floor, Teli Gali Cross Lane, Andheri (East), Mumbai – 400 069, Maharashtra, India

Tel. No.:

91-22-26841707/ 40/ 26833756

Fax No.:

91-22-26843745

E-Mail :

samrat@bom4.vsnl.net.in

Area :

500 sq. ft.

Location :

Leased

 

 

Corporate Office 2 :

701/702, Business Square, M.A. Road, Andheri (West), Mumbai – 400 058, Maharashtra, India

Tel. No.:

91-22-26701050/ 1/ 2

Fax No.:

91-22-26701053

E-Mail :

samrat@bom4.vsnl.net.in

 

 

Factory 2 :

Plot No.A2/3444, G.I.D.C., Phase–4, Ankleshwar – 393 002, Gujarat, India

 

 

DIRECTORS

 

As on 29.09.2012

 

Name :

Mr. Lalit Damodar Mehta

Designation :

Managing Director

Address :

B/74, Roop Darshan, Juhu Lane, Andheri (West), Mumbai – 400 058, Maharashtra, India

Date of Birth/Age :

08.08.1936

Qualification :

B. Sc , LLB

Date of Appointment :

01.04.2011

PAN No.:

AABPM9691E

DIN No.:

00216681

 

 

Name :

Mr. Rajesh Lalit Mehta

Designation :

Whole Time Director

Address :

B/74, Roop Darshan, Juhu Lane, Andheri (West), Mumbai – 400 058, Maharashtra, India

Date of Birth/Age :

25.06.1964

Qualification :

B.Com, ACA

Date of Appointment :

01.04.2011

PAN No.:

AABPM9692H

DIN No.:

00216731

 

 

Name :

Mr. Mahendra Indulal Pipalia

Designation :

Director

Address :

A/15, Shatdal, Azad Lane, S.V. Road, Andheri (West), Mumbai – 400 058, Maharashtra, India

Date of Birth/Age :

09.11.1963

Qualification :

B.Com, ACA

Date of Appointment :

17.03.2003

DIN No.:

00216959

 

 

Name :

Mr. Samir Harsukhrai Kothary

Designation :

Director

Address :

B/45, Roop Darshan, Juhu Lane, Andheri (West), Mumbai – 400 058, Maharashtra, India

Date of Birth/Age :

10.10.1962

Qualification :

B. Sc, DBM

Date of Appointment :

30.07.2003

DIN No.:

00216603

 

 

Name :

Mr. Hitendra Narendra Shah

Designation :

Director

Address :

B/308, Alka Society, S.V. Road, Andheri (West), Mumbai – 400 058, Maharashtra, India

Date of Birth/Age :

26.10.1967

Qualification :

B.Com.

Date of Appointment :

30.12.2005

DIN No.:

00216891

  

 

SHAREHOLDING PATTERN

 

As on 30.06.2013

 

Category of Shareholders

No. of Shares

Percentage of Holding

(A) Shareholding of Promoter and Promoter Group

 

 

http://www.bseindia.com/include/images/clear.gif(1) Indian

 

 

http://www.bseindia.com/include/images/clear.gifIndividuals / Hindu Undivided Family

1445431

46.78

http://www.bseindia.com/include/images/clear.gifSub Total

1445431

46.78

http://www.bseindia.com/include/images/clear.gif(2) Foreign

 

 

Total shareholding of Promoter and Promoter Group (A)

1445431

46.78

(B) Public Shareholding

 

 

http://www.bseindia.com/include/images/clear.gif(1) Institutions

 

 

http://www.bseindia.com/include/images/clear.gifForeign Institutional Investors

100000

3.24

http://www.bseindia.com/include/images/clear.gifSub Total

100000

3.24

http://www.bseindia.com/include/images/clear.gif(2) Non-Institutions

 

 

http://www.bseindia.com/include/images/clear.gifBodies Corporate

148399

4.80

http://www.bseindia.com/include/images/clear.gifIndividuals

 

 

http://www.bseindia.com/include/images/clear.gifIndividual shareholders holding nominal share capital up to Rs. 0.100 Million

946412

30.63

http://www.bseindia.com/include/images/clear.gifIndividual shareholders holding nominal share capital in excess of Rs. 0.100 Million

397088

12.85

http://www.bseindia.com/include/images/clear.gifAny Others (Specify)

52370

1.69

http://www.bseindia.com/include/images/clear.gifClearing Members

6970

0.23

http://www.bseindia.com/include/images/clear.gifNon Resident Indians

45400

1.47

http://www.bseindia.com/include/images/clear.gifSub Total

1544269

49.98

Total Public shareholding (B)

1644269

53.22

Total (A)+(B)

3089700

100.00

(C) Shares held by Custodians and against which Depository Receipts have been issued

0

0.00

http://www.bseindia.com/include/images/clear.gif(1) Promoter and Promoter Group

0

0.00

http://www.bseindia.com/include/images/clear.gif(2) Public

0

0.00

http://www.bseindia.com/include/images/clear.gifSub Total

0

0.00

Total (A)+(B)+(C)

3089700

0.00

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturer, Exporter and Importer of Pharmaceutical Chemicals.

 

 

Products :

Item Code

Product Description

28276010

Potassium Iodide

28276020

Sodium Iodide

28012000

Iodine

 

 

Terms :

 

Selling :

Cash and Credit

 

 

Purchasing :

Cash and Credit

 

 

PRODUCTION STATUS (AS ON 31.03.2011)

 

Particulars

Unit

Installed Capacity

Actual Production

Pharmaceutical Chemicals

MT

415.20

372.90

 

 

 

 

 

 

GENERAL INFORMATION

 

Customers :

End Users

 

 

No. of Employees :

30 (Approximately)

 

 

Bankers :

  • ICICI Bank Limited, Landmark Race Cource Circle, Alkapuri, Vadodara – 390 015, Gujarat, India
  • ICICI Bank Limited, Sagar Avenue, S.V. Road, Andheri (West), Mumbai – 400 058, Maharashtra, India
  • CITI Bank N.A., Kalpachandra, S.V. Road, Andheri (West), Mumbai – 400 058, Maharashtra, India
  • HDFC Bank Limited, Jamuna Apartments, S.V. Road, Andheri (West), Mumbai – 400 058, Maharashtra, India
  • State Bank of India, Rahul Apartments, S.V. Road, Andheri (West), Mumbai – 400 058, Maharashtra, India

 

 

Facilities :

Secured Loans

31.03.2012

(Rs. in Millions)

31.03.2011

(Rs. in Millions)

LONG-TERM BORROWINGS

 

 

Rupee term loans from banks

13.202

0.000

SHORT-TERM BORROWINGS

 

 

Loans repayable on demand from banks

(Stock, Book Debts and Fixed Asset)

21.006

16.324

Total

34.208

16.324

 

 

 

Banking Relations :

--

 

 

Auditors :

 

Name :

Shah, Shah and Shah

Chartered Accountants

Address :

502, Damji Shamji Trade Centre, Vidyavihar (West), Mumbai – 400 086, Maharashtra, India

Tel. No.:

91-22-25100861/ 25109990

E-Mail :

info@shah3ca.com

Income-tax PAN of auditor or auditor's firm :

AALFS8301D

 

 

CAPITAL STRUCTURE

 

As on 29.09.2012

 

Authorised Capital :

No. of Shares

Type

Value

Amount

5000000

Equity Shares

Rs.10/- each

Rs.50.000 millions

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

3089700

Equity Shares

Rs.10/- each

Rs.30.897 Millions

 

 

 

 

 

 

 

 

 

 


 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

SOURCES OF FUNDS

 

 

31.03.2012

31.03.2011

I.              EQUITY AND LIABILITIES

 

 

 

(1) Shareholders' Funds

 

 

 

(a) Share Capital

 

30.897

30.897

(b) Reserves & Surplus

 

94.069

56.297

(c) Money received against share warrants

 

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

 

0.000

0.000

 

 

 

 

(3) Non-current liabilities

 

 

 

(a) Long-term borrowings

 

13.202

0.000

(b) Deferred tax liabilities (Net)

 

2.502

2.320

(c) Other long term liabilities

 

0.000

0.000

(d) Long-term provisions

 

0.000

0.000

 

 

 

 

(4) Current liabilities

 

 

 

(a) Short term borrowings

 

21.006

16.324

(b) Trade payables

 

138.553

79.280

(c) Other current liabilities

 

0.381

0.228

(d) Short-term provisions

 

14.546

2.594

TOTAL

 

315.156

187.940

 

 

 

 

II.            ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

 

36.297

25.394

(ii) Intangible Assets

 

0.018

0.034

(iii) Capital work-in-progress

 

27.600

4.328

(iv) Intangible assets under development

 

0.000

0.000

(b) Non-current Investments

 

0.000

0.000

(c) Deferred tax assets (net)

 

0.000

0.000

(d)  Long-term Loan and Advances

 

1.027

0.830

(e) Other Non-current assets

 

1.376

1.124

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

 

0.000

0.000

(b) Inventories

 

73.673

30.806

(c) Trade receivables

 

105.013

93.700

(d) Cash and cash equivalents

 

44.487

14.961

(e) Short-term loans and advances

 

0.216

0.180

(f) Other current assets

 

25.449

16.583

TOTAL

 

315.156

187.940

 

 

SOURCES OF FUNDS

 

 

 

31.03.2010

SHAREHOLDERS FUNDS

 

 

 

1] Share Capital

 

 

30.897

2] Share Application Money

 

 

0.000

3] Reserves & Surplus

 

 

42.875

4] (Accumulated Losses)

 

 

0.000

NETWORTH

 

 

73.772

LOAN FUNDS

 

 

 

1] Secured Loans

 

 

16.292

2] Unsecured Loans

 

 

0.000

TOTAL BORROWING

 

 

16.292

DEFERRED TAX LIABILITIES

 

 

2.212

 

 

 

 

TOTAL

 

 

92.276

 

 

 

 

APPLICATION OF FUNDS

 

 

 

 

 

 

 

FIXED ASSETS [Net Block]

 

 

23.039

Capital work-in-progress

 

 

0.000

 

 

 

 

INVESTMENT

 

 

0.000

DEFERRED TAX ASSETS

 

 

0.000

 

 

 

 

CURRENT ASSETS, LOANS & ADVANCES

 

 

 

 

Inventories

 
 
14.154

 

Sundry Debtors

 
 
75.949

 

Cash & Bank Balances

 
 
30.423

 

Other Current Assets

 
 
4.854

 

Loans & Advances

 
 
2.047

Total Current Assets

 
 
127.427

Less : CURRENT LIABILITIES & PROVISIONS

 

 

 

 

Sundry Creditors

 

 
57.452

 

Other Current Liabilities

 
 
0.200

 

Provisions

 
 
0.538

Total Current Liabilities

 
 
58.190

Net Current Assets

 
 
69.237

 

 

 

 

MISCELLANEOUS EXPENSES

 

 

0.000

 

 

 

 

TOTAL

 

 

92.276

  


PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

31.03.2012

31.03.2011

31.03.2010

 

SALES

 

 

 

 

 

Revenue from operations

695.431

434.296

479.695

 

 

Other Income

2.508

1.455

0.224

 

 

TOTAL                                     (A)

697.939

435.751

479.919

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Cost of materials consumed

649.748

377.379

461.396

 

 

Changes in inventories of finished goods, work-in-progress and stock-in-trade

(58.877)

(4.013)

 

 

 

Employee benefit expense

5.048

3.798

 

 

 

Other expenses

35.942

33.074

 

 

 

TOTAL                                     (B)

631.861

410.238

461.396

 

 

 

 

 

Less

PROFIT/ (LOSS) BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (A-B)     (C)

66.078

25.513

18.523

 

 

 

 

 

Less

FINANCIAL EXPENSES                                    (D)

6.160

2.792

3.037

 

 

 

 

 

 

PROFIT/ (LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D)                               (E)

59.918

22.721

15.486

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION                     (F)

1.928

1.613

1.465

 

 

 

 

 

 

PROFIT/ (LOSS) BEFORE TAX (E-F)                 (G)

57.990

21.108

14.021

 

 

 

 

 

Less

TAX                                                                  (H)

20.217

7.686

2.748

 

 

 

 

 

 

PROFIT/ (LOSS) AFTER TAX (G-H)                   (I)

37.773

13.422

11.273

 

 

 

 

 

Add

PREVIOUS YEARS’ BALANCE BROUGHT FORWARD

56.297

42.875

31.602

 

 

 

 

 

 

BALANCE CARRIED TO THE B/S

94.070

56.297

42.875

 

 

 

 

 

 

EARNINGS IN FOREIGN CURRENCY

 

 

 

 

 

F.O.B. Value of Exports

253.221

111.057

64.821

 

TOTAL EARNINGS

253.221

111.057

64.821

 

 

 

 

 

 

IMPORTS

 

 

 

 

 

Raw Materials

NA

314.956

301.544

 

TOTAL IMPORTS

NA

314.956

301.544

 

 

 

 

 

 

Earnings/ (Loss) Per Share (Rs.)

12.23

4.34

3.96

 

 

Particulars

 

 

 

31.03.2013

Sales Turnover (Approximately)

 

 

700.000

 

 

 

 

 

The above information has been parted by Mr. Rajesh Mehta.

 

 

QUARTERLY RESULTS

 

PARTICULARS

 

30.06.2012

(1st Quarter)

30.09.2012

(2nd Quarter)

31.12.2012

(3rd Quarter)

31.03.2013

(4th Quarter)

Net Sales

178.100

198.000

158.300

172.700

Total Expenditure

175.800

189.600

154.800

172.600

PBIDT (Excl OI)

2.300

8.400

3.500

0.100

Other Income

0.400

0.500

0.000

2.600

Operating Profit

2.700

8.900

3.500

2.700

Interest

1.700

4.000

1.700

2.000

Exceptional Items

0.000

0.000

0.000

0.000

PBDT

0.900

4.900

1.800

0.700

Depreciation

0.600

0.600

0.600

0.600

Profit Before Tax

0.300

4.300

1.100

0.100

Tax

0.200

1.300

0.200

0.100

Provisions and contingencies

0.000

0.000

0.000

0.000

Profit After Tax

0.200

3.000

0.900

0.000

Extraordinary Items

0.000

0.000

0.000

0.000

Prior Period Expenses

0.000

0.000

0.000

0.000

Other Adjustments

0.000

0.000

0.000

0.000

Net Profit

0.200

3.000

0.900

0.000

 

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2012

31.03.2011

31.03.2010

PAT / Total Income

(%)

5.41
3.08

2.35

 

 

 
 

 

Net Profit Margin

(PBT/Sales)

(%)

8.34
4.86

2.92

 

 

 
 

 

Return on Total Assets

(PBT/Total Assets}

(%)

20.17
11.62

9.32

 

 

 
 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.46
0.24

0.19

 

 

 
 

 

Debt Equity Ratio

(Total Debt/Networth)

 

0.27
0.19

0.22

 

 

 
 

 

Current Ratio

(Current Asset/Current Liability)

 

1.43
1.59

2.19

 

 

LOCAL AGENCY FURTHER INFORMATION

 

DETAILS OF CURRENT MATURITIES OF LONG-TERM DEBT: NOT AVAILABLE

 

Sr. No.

Check List by Info Agents

Available in Report (Yes / No)

1]

Year of Establishment

Yes

2]

Locality of the firm

Yes

3]

Constitutions of the firm

Yes

4]

Premises details

Yes

5]

Type of Business

Yes

6]

Line of Business

Yes

7]

Promoter's background

Yes

8]

No. of employees

Yes

9]

Name of person contacted

Yes

10]

Designation of contact person

Yes

11]

Turnover of firm for last three years

Yes

12]

Profitability for last three years

Yes

13]

Reasons for variation <> 20%

----------------------

14]

Estimation for coming financial year

No

15]

Capital in the business

Yes

16]

Details of sister concerns

No

17]

Major suppliers

No

18]

Major customers

No

19]

Payments terms

Yes

20]

Export / Import details (if applicable)

No

21]

Market information

----------------------

22]

Litigations that the firm / promoter involved in

----------------------

23]

Banking Details

Yes

24]

Banking facility details

Yes

25]

Conduct of the banking account

----------------------

26]

Buyer visit details

----------------------

27]

Financials, if provided

Yes

28]

Incorporation details, if applicable

Yes

29]

Last accounts filed at ROC

Yes

30]

Major Shareholders, if available

Yes

31]

Date of Birth of Proprietor/Partner/Director, if available

Yes

32]

PAN of Proprietor/Partner/Director, if available

Yes

33]

Voter ID No of Proprietor/Partner/Director, if available

No

34]

External Agency Rating, if available

No

 

 

OPERATIONS

 

The company has performed reasonably well during the year. In a highly competitive business environment, the Company achieved a turnover of Rs.754.324 millions as against Rs.475.571 millions achieved last year - a increase of around 59%. Production of 300.04 tons of pharmaceutical chemicals was achieved during the year.

 

EXPORTS

 

During the year 2011-2012 the company's export division registered sales of Rs.253.221 millions, up from Rs.111.057 millions last year. The Company has initiated several export promotion measures to increase exports. The products of the Company have been well accepted in the international market and the Company expects better export turnover in the coming year.

 

MANAGEMENT DISCUSSION AND ANALYSIS

 

INDUSTRY STRUCTURE AND DEVELOPMENTS

 

The Company is a producer of pharmaceutical chemicals. The intermediates produced are used in pharmaceutical and chemical industries. The Company is amongst the manufacturers who produce for local and international needs of the pharmaceuticals and chemicals industry. The pharmaceutical and chemical industry is growing at a rapid pace every year. This results into growth of the support or intermediate industry like us.

 

PRODUCT PERFORMANCE

 

The company has two plants producing varied items. The basic purpose of producing in two different plants is to improve efficiency and manageability. The Company shall achieve sustainable growth in both plants by modernization and automation of operations. According to the Directors, these plants facilitate better division of labour, enable them to develop expertise in each plant and their respective items, and hence improve productivity and profitability of the Company.

 

OUTLOOK

 

According to Yes Bank Report titled "Indian Pharmaceutical Industry: Vision 2015", the Indian Pharmaceutical and Chemical industry is projected to grow at an annual rate of 14.2%. Currently valued at USD 10 Billion, the projected turnover to touch USD 50 Billion by the year 2015.

 

FINANCIAL PERFORMANCE WITH RESPECT TO OPERATIONAL PERFORMANCE

 

A satisfactory business performance with average volume growth in key products and business units, combined with productivity improvement, cost management and working capital management have contributed to the good operating results for the year. Also sharp focus on cost and margins has resulted in enhanced operational efficiency.

 

 

BANKERS CHARGES REPORT AS PER REGISTRY

 

Corporate identity number of the company

L24230GJ1992PLC017820

Name of the company

SAMRAT PHARMACHEM LIMITED

Address of the registered office or of the principal place of  business in India of the company

Plot No.A2/3445, G.I.D.C., Phase–4, Ankleshwar – 393 002, Gujarat, India

E-Mail: samrat@bom4.vsnl.net.in

This form is for

Modification of charge

Charge identification number of the modified 

80001467

Type of charge

  • Book Debts
  • Movable Property (not being pledge)
  • Others (All current assets and moveable fixed assets)

Particular of charge holder

ICICI Bank Limited, Landmark Race Cource Circle, Alkapuri, Vadodara – 390 015, Gujarat, India

E-Mail: charul.jain@icicibank.com

CIN No.: L65190GJ1994PLC021012

Nature of description of the instrument creating or modifying the charge

As per Supplemental Deed of Hypothecation dated October 20, 2012 executed for creation of charge on current assets on pari passu basis and first charge on moveable properties of the company to secure working capital limit of Rs.195.000 millions

Date of instrument Creating the charge

20.10.2012

Amount secured by the charge

Rs.195.000 millions

Brief particulars of the principal terms and conditions and extent and operation of the charge

Rate of Interest:

As per sanction terms

 

Terms of Repayment:

As per sanction terms

 

Margin:

As per sanction terms

 

Extent and Operation of the charge:

First charge in favour of the Bank by way of hypothecation of the Company’s entire stocks of raw materials, semi-finished and finished goods, consumable stores and spares and such other moveables including book-debts, bills whether documentary or clean, outstanding monies, receivables, both present and future, in a form and manner satisfactory to the Bank, ranking pari passu with other working capital bankers.

 

Hypothecation on the present and future movable, fixed assets of the company.

 

Others:

As per sanction terms

Short particulars of the property charged

First charge in favour of the Bank by way of hypothecation of the Company’s entire stocks of raw materials, semi-finished and finished goods, consumable stores and spares and such other moveables including book-debts, bills whether documentary or clean, outstanding monies, receivables, both present and future, in a form and manner satisfactory to the Bank, ranking pari passu with other working capital bankers. Hypothecation on the present and future movable, fixed assets of the company.

Particulars of the present modification 

Previously first charge was created on current assets and moveable properties to secure working capital limits of Rs 155.000 millions.

Present modification is for securing the aggregate limit of Rs.195.000 millions (enhanced from Rs.155.000 millions to Rs.195.000 millions). Also, the charge on current assets is modified to first pari passu charge.

 

 

STATEMENT OF STANDALONE AUDITED RESULTS FOR THE QUARTER AND FOR THE YEAR ENDED 31 MARCH 2013

(Rs. in Millions)

 

 

Quarter Ended

Year Ended

No.

Particulars

31.03.2013

31.12.2013

31.03.2013

1.

(a) Net Income from Sales and Services

171.634

155.931

705.212

 

(b) Other Operating Income

1.075

0.068

2.657

 

Total income

203.9403

187.3203

739.1003

2.

Expenses

 

 

 

 

(a) (Increase)/ Decrease in Stock in Trade/ WIP

(32.699)

(1.822)

(16.009)

 

(b) Consumption of Raw Material

190.514

156.256

668.782

 

(c) Purchase of Traded Goods

0.000

0.000

0.000

 

(d) Employee Benefits Expense

2.725

2.339

8.540

 

(e) Depreciation

0.612

0.559

2.415

 

(f) Other Expenditure

 

 

 

 

(i) Manufacturing Expenses

8.639

4.462

19.126

 

(ii) Administrative Expenses

1.729

2.176

7.102

 

(iii) Selling and Distribution Expenses

1.712

2.548

5.201

 

Total Expenses

173.232

170.162

695.157

3.

Profit/ (Loss) from Operations before Other Income, Interest and Exceptional Items

(0.523)

(14.163)

12.712

4.

Other Income

2.611

1.004

2.611

5.

Profit / (Loss) before Interest and Exceptional Items

2.088

(13.159)

15.323

6.

Interest

2.066

1.407

9.506

7.

Profit / (Loss) from Ordinary Activities after Finance Costs but before Exceptional Items

0.082

(14.566)

5.817

8.

Exceptional Items

0.000

0.000

0.000

9.

Profit / (loss) from Ordinary Activities before Tax

0.082

(14.566)

5.817

10.

Tax Expense (including differed tax)

0.095

1.828

1.813

11.

Net Profit/ (Loss) from Ordinary Activities after Tax

(0.013)

(16.394)

4.004

12

Extraordinary Items (Net of tax expenses)

0.00

0.000

0.000

13

Net Profit/ (Loss) for the period

(0.013)

(16.394)

4.004

14.

Paid-up Equity Share Capital

30.897

30.897

30.897

15.

Reserve excluding Revaluation Reserves as per Balance Sheet of Previous Accounting Year

--

--

98.072

16.

Earnings Per Share (of Rs 10/- each)

 

 

 

 

a) Basic and diluted EPS before extraordinary item for the period year to date previous year

0.00

5.31

1.30

 

b) Basic and diluted EPS after extraordinary item for the period year to date previous year

0.00

5.31

1.30

 

 

 

 

 

17

Public Shareholding

 

 

 

 

-    Number of Shares

1644269

1664521

1644269

 

-    Percentage of Shareholding

53.22

53.87

53.22

18

Promoters and Promoter Group Shareholding

 

 

 

 

a) Pledged/ Encumbered

 

 

 

 

-    Number of Shares

0.00

0.00

0.00

 

-    Percentage of Shares (as a % of the total Shareholding of Promoter and Promoter Group)

0.00

0.00

0.00

 

-    Percentage of Shares (as a % of the total Share Capital of the Company)

0.00

0.00

0.00

 

b) Non-Encumbered

 

 

 

 

-    Number of Shares

1445431

1425179

1445.431

 

-    Percentage of Shares (as a % of the total Shareholding of Promoter and Promoter Group)

100.00

100.00

100.00

 

-    Percentage of Shares (as a % of the total Share Capital of the Company)

46.78

46.13

46.78

 

 

STANDALONE STATEMENT OF ASSETS AND LIABILITIES

(Rs. in Millions)

Particulars

31.03.2013

EQUITY AND LIABILITIES

 

SHAREHOLDERS' FUNDS:

 

(a) Capital

30.897

(b) Reserves and Surplus

98.072

(c) Money Received Against Snare Warrants

0.000

Sub total- Shareholders' Fund

128.969

SHARE APPLICATION MONEY PENDING ALLOTMENT

0.000

NON - CURRENT LIABILITIES

 

(a) Long-Term Borrowings

10.088

(b) Deferred Tax Liabilities (Net)

2.991

(c) Other Long-Term Liabilities

0.000

(d) Long-Term Provisions

0.000

Sub total- Non Current Liabilities

13.079

CURRENT LIABILITIES

 

(a) Short-Term Borrowings

32.956

(b) Trade Payables

159.690

(c) Other Current Liabilities

4.345

(d) Short-Term Provisions

0.000

Sub total- Current Liabilities

196.991

 

 

Total - Equity and Liabilities

 

 

 

ASSETS

 

NON-CURRENT ASSETS

 

(a) Fixed Assets

72.897

(b) Non-Current Investment

0.000

(c) Deferred Tax Assets (Not)

0.000

(d) Long-Term Loans And Advances

1.337

(c) Other Non-Current Assets

1.707

Sub total- Non Current Assets

75.941

CURRENT ASSETS

 

(a) Current Investment

0.000

(b) Inventories

97.297

(c) Trade Receivables

117.677

(d) Cash And Cash Equivalents

25.625

(e) Short-term loans and advances

0.300

(f) Other current assets

22.199

Sub total- Current Assets

263.098

 

 

Total - Assets

339.039

 

STATEMENT OF APPROPRIATIONS

(Rs. in Millions)

Particulars            

31.03.2013

1. Total Turnover And Other Receipts

710.480

2. Gross Profit:

(Before Deducting Any Of The Following)

17.737

(a) Interest

9.506

(b) Depreciation

2.415

(c) Tax Liability

1.323

(d) Net Deferred Tax Liability

0.489

(e) Preliminary Expenses w/off

0.000

(f) Loss/(Profit) On Sale of Assets

0.000

(g) Loss/(Profit) On sale of Investments

0.000

3. Net Profit Available For Appropriation

4.003

4. Provision-Investment Allowance Reserve

0.000

5. Net Profit/Loss

4.003

(a) Add/Less:

 

b/f From Last Year's Balance

94.069

(b) Other Adjustments, If Any

0.000

Less: Transferred To

 

(I) General Reserve

0.000

(II) Debenture Redemption Reserve

0.000

6. Dividend:

 

(a) Per Ordinary Shares Rs.

0.000

No, Of Shares

3089700

(Last Year Rs. Nil Per Share)

 

(b) Per Preference Shares Rs.

0

No. of Shares

0

7. Balance carried forward

98.072

 

Notes :

 

1. The Above results were reviewed by the Audit Committee of the Board of Directors.

 

2. The above results have been taken on record by the board of Director at it meeting held on Thursday, 30 May 2013 at the Corporate Office of the Company.

 

3. The above figures are after accounting for a net foreign exchange loss of Rs.13.493 Millions during the year.

 

4. The figures of the quarter ended 31st March 2013 and 31st March 2012 are the balancing figures between the audited figures in respect of full financial years and the published (unaudited) up to the third quarter of relevant financial year.

 

5. Information on investor complaints pursuant to clause 41 of the listing agreement for the quarter ended 31 March, 2013

 

Opening Balance as on 31.12.2012

Received during the quarter

Disposed of during the quarter

Closing Balance as on 31.03.2013

 

6. The figures for the previous period have been regrouped where necessary to conform to current period classification.

 

 

FIXED ASSETS:

 

Tangible Assets

 

·         Land

·         Building

·         Plant and Machinery

·         Furniture and Fixtures

·         Vehicles

·         Office Equipments

 

Intangible Assets

 

·         Computer Software

 

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                           None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                        None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                        None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 


 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.60.80

UK Pound

1

Rs.91.95

Euro

1

Rs.80.37 

 

 

INFORMATION DETAILS

 

Information Gathered by :

NYA

 

 

Report Prepared by :

RAJ

 


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

4

PAID-UP CAPITAL

1~10

4

OPERATING SCALE

1~10

6

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

6

--PROFITABILIRY

1~10

5

--LIQUIDITY

1~10

6

--LEVERAGE

1~10

6

--RESERVES

1~10

6

--CREDIT LINES

1~10

6

--MARGINS

-5~5

-

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

NO

--LISTED

YES/NO

YES

--OTHER MERIT FACTORS

YES/NO

YES

DEFAULTER

 

 

--RBI

YES/NO

NO

--EPF

YES/NO

NO

TOTAL

 

49

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

-

NB

                                       New Business

-

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.